Panzara Michael A. 4
4 · Athira Pharma, Inc. · Filed Mar 21, 2022
Insider Transaction Report
Form 4
Panzara Michael A.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-03-18+27,742→ 27,742 totalExercise: $10.62Exp: 2032-03-17→ Common Stock (27,742 underlying)
Footnotes (1)
- [F1]One thirty-sixth of the shares subject to the option will vest on April 18, 2022 and one thirty-sixth of the shares subject to the option will vest each month thereafter.